Pages that link to "Q37773286"
Jump to navigation
Jump to search
The following pages link to gammadelta T cells in cancer immunotherapy: current status and future prospects (Q37773286):
Displaying 22 items.
- Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset (Q24339540) (← links)
- Haploidentical Hematopoietic Stem Cell Transplantation: Expanding the Horizon for Hematologic Disorders (Q26767501) (← links)
- Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies (Q34517192) (← links)
- Clinical applications of gamma delta T cells with multivalent immunity (Q34677859) (← links)
- Challenges and future perspectives of T cell immunotherapy in cancer (Q35843507) (← links)
- CD73 Expressed on γδ T Cells Shapes Their Regulatory Effect in Experimental Autoimmune Uveitis (Q35937473) (← links)
- Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: role in osteoclast-mediated NK cell activation (Q36299558) (← links)
- Bispecific T-cells expressing polyclonal repertoire of endogenous γδ T-cell receptors and introduced CD19-specific chimeric antigen receptor (Q36659270) (← links)
- Current progress in γδ T-cell biology. (Q37729208) (← links)
- Targeting gamma delta T cells for cancer immunotherapy: bench to bedside (Q38179172) (← links)
- Immune modulation by butyrophilins (Q38233770) (← links)
- γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer Immunotherapy (Q38271585) (← links)
- Aminobisphosphonates prevent the inhibitory effects exerted by lymph node stromal cells on anti-tumor Vδ 2 T lymphocytes in non-Hodgkin lymphomas. (Q39158802) (← links)
- Analysis of tumor-infiltrating gamma delta T cells in rectal cancer (Q39704837) (← links)
- Activation status of γδ T cells dictates their effect on osteoclast generation and bone resorption. (Q40942283) (← links)
- RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma. (Q41450925) (← links)
- How to exploit stress-related immunity against Hodgkin's lymphoma: Targeting ERp5 and ADAM sheddases. (Q42740131) (← links)
- Sensing Bad: Are Co-stimulatory CAR-Expressing γδ T Cells Safer? (Q45866963) (← links)
- Zoledronic acid sensitizes rhabdomyosarcoma cells to cytolysis mediated by human γδ T cells (Q47270508) (← links)
- Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation (Q50025651) (← links)
- Checkpoint Blockade Rescues the Repressive Effect of Histone Deacetylases Inhibitors on γδ T Cell Function. (Q64968682) (← links)
- Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells (Q91868641) (← links)